Organization · Venture Capital
Deerfield Management
Deerfield Management is a New York City-based investment management firm specializing in healthcare investments, managing over $15 billion in assets across more than 200 companies. The firm focuses on both public and private investments in sectors such as biotechnology, medical devices, and digital health.
Overview
What Deerfield Management does
What Deerfield Management is
Deerfield Management is a New York City-based investment management firm specializing in healthcare investments, managing over $15 billion in assets across more than 200 companies. The firm focuses on both public and private investments in sectors such as biotechnology, medical devices, and digital health.
How it participates in the startup ecosystem
The current public profile supports funder and event host and publisher capabilities. Each capability below is shown separately so organization identity and role-specific information do not get conflated.
Operational profile
Organization status and context
Organization status describes the entity itself. Funding and program availability appear within the relevant capability profile.
- Operational status
- Active
- Organization type
- Venture Capital
- Founded
- Founded in 1994
- Approximate age
- About 32 years
- Structured capabilities
- Funder · Event host · Publisher
- Last reviewed
- March 27, 2026
Official channels
Find Deerfield Management elsewhere
Open the official website or a supported primary organization account.
Capability profile
Deerfield Management as a funder
Investment thesis
Deerfield Management focuses exclusively on advancing healthcare through strategic investments in therapeutics, medical devices, and innovative healthcare services. The firm aims to support companies at all stages of development, leveraging its extensive expertise and philanthropic initiatives to drive impactful healthcare solutions.
Focus narrative
Deerfield invests in a diverse portfolio of over 200 private and public companies across the healthcare ecosystem. The firm focuses on sectors such as therapeutics, medical devices, healthcare services, diagnostics, and digital health. By providing flexible funding models, Deerfield supports companies from early-stage startups to mature enterprises, ensuring a comprehensive approach to healthcare innovation.
Value beyond capital
Deerfield Management adds value to its portfolio companies through strategic guidance, access to a vast network of industry experts, and resources for research and development. The firm's philanthropic initiatives also enhance its impact, as a portion of profits from its Healthcare Innovations Fund III is donated to the Deerfield Foundation, which focuses on improving children's health worldwide.
Focus and fit
- Stages
- Friends and Family · Angel · Accelerator · Pre-seed · Seed · Seed+ · Series A · Series A+ · Series B · Series B+ · Series C · Series C+ · Series D · Series E · Series F · Growth Equity · Pre-IPO · Ipo
- Sectors
- Artificial Intelligence
- Regions
- Global · North America
Availability
- Currently deploying
- Yes
Portfolio and track record
- Recorded portfolio count
- 200
- Recorded notable exits
- Nuvalent, Bicara Therapeutics, and Arvinas
Portfolio context
Notable portfolio companies include: Neomorph: Developing new medicines against 'undruggable' targets. Alo: A healthcare services platform assisting independent physicians in managing their practices. Deerfield Catalyst: Focused on transforming medical device innovations into commercial products. Additionally, Deerfield has early investments in publicly traded companies like Nuvalent, Bicara Therapeutics, and Arvinas.
Capability profile
Deerfield Management as an event host
Event focus
Deerfield Management invests in a diverse portfolio of over 200 private and public companies across the healthcare ecosystem. Their focus includes sectors such as therapeutics, medical devices, healthcare services, diagnostics, and digital health. The firm provides flexible funding models and supports companies at all stages of development, from early-stage startups to mature companies.
Format narrative
Deerfield hosts the AML Summit, an annual event aimed at advancing research for acute myeloid leukemia, and engages in various industry events to foster collaboration and innovation.
Participant value
The XSeed Awards provide funding of up to $500,000 to support underfunded and underrepresented life science startups in New York City.
Format and cadence
- Event types
- summit
- Recurrence
- annual
- Modality
- in-person
- Startups can present
- No
Availability
- Registration state
- Not currently accepting
Audience and fit
- Stages
- Pre-seed · Seed · Series A · Growth Equity
- Audience
- Founders · Investors
- Sectors
- Healthcare · Medical Devices · Diagnostics · Digital Health
- Regions
- North America
Speakers and past editions
Speakers
Key team members include Jim Flynn, Managing Partner; Konstantinos Aprilakis, M.D., Partner; Sumner Anderson, Partner; Nicholas Bishop, Ph.D., Partner; Brian Bizoza, M.D., Partner; and Anne Daub, Partner.
Capability profile
Deerfield Management as a publisher
Editorial focus
Deerfield Management Company is dedicated to advancing healthcare by investing in a diverse portfolio of over 200 private and public companies across the healthcare ecosystem. Their focus includes therapeutics, medical devices, healthcare services, diagnostics, and digital health. The firm provides flexible funding models and supports companies at all stages of development, from startups to mature enterprises.
Audience value
Deerfield offers institutional healthcare investment opportunities with a focus on innovative healthcare solutions. Their commitment to philanthropy and support for underrepresented startups distinguishes them in the venture capital landscape.
Format and cadence
- Content formats
- research-report
Availability
- Guest pitch state
- Not currently accepting
Audience and focus
- Audience
- Investors · Founders
- Sectors
- Healthcare
- Regions
- North America
Flagship work and coverage
Flagship properties
Deerfield runs the XSeed Awards, providing funding to underfunded and underrepresented life science startups in New York City. They also host the AML Summit, an annual event focused on advancements in hematology and related fields.
Notable coverage
Deerfield has been recognized for its unique philanthropic model, where a portion of profits from the Healthcare Innovations Fund III is donated to the Deerfield Foundation, aimed at improving children's health worldwide. The firm has received significant industry recognition and has been covered by BioPharma Dive and FierceBiotech.
Common questions
What to know about Deerfield Management
Upseed classifies Deerfield Management under the Venture Capital organization type. Its current public profile includes funder, event host, and publisher capabilities.
Source and update disclosure
Know what this page is based on
Source basis
Public organization and program material, official websites, and structured Upseed records.
Last reviewed
March 27, 2026
Known limits
Capability profiles appear only when a structured public profile also contains decision-useful role evidence. Terms and availability can change.
Upseed is an independent guide. It is not affiliated with or endorsed by the organization described on this page.